QT
CHRS icon

Quantamental Technologies’s Coherus Oncology CHRS Stock Holding History

Quantamental Technologies’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$38.6K Buy
+10,329
New +$47.7K 0.04% 279
2023
Q2 		– Sell
-16,637
Closed -$114K – 494
2023
Q1 		$114K Buy
+16,637
New +$129K 0.06% 376
2019
Q4 		– Sell
-12,325
Closed -$250K – 578
2019
Q3 		$250K Buy
+12,325
New +$246K 0.08% 416
2019
Q1 		– Sell
-1,286
Closed -$12K – 1508
2018
Q4 		$12K Buy
+1,286
New +$14.9K 0.01% 1116

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Quantamental Technologies's CHRS Position: Q3 2023 in Review

Quantamental Technologies opened a new position in Coherus Oncology (CHRS) in Q3 2023: 10,329 shares worth $38.6K. The stake represents 0.04% of the portfolio and ranks #279 among its holdings. This is a return to the name: Quantamental Technologies previously reported a position in CHRS as recently as Q1 2023.

Quantamental Technologies first reported a position in CHRS in Q4 2018 and has held it in 4 quarters since. The position peaked at $250K in Q3 2019. 169 funds tracked by Wall St. Rank hold CHRS as of Q3 2023.

  • Quantamental Technologies held 10,329 shares of Coherus Oncology worth $38.6K as of Q3 2023.
  • Coherus Oncology was a new Quantamental Technologies position in Q3 2023.
  • Coherus Oncology made up 0.04% of Quantamental Technologies's portfolio in Q3 2023, its #279 holding.
  • Quantamental Technologies first reported a position in Coherus Oncology in Q4 2018 and has held it in 4 quarters since.
  • Quantamental Technologies's Coherus Oncology position peaked at $250K in Q3 2019.
  • 169 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.